Evidence map›Paper›PMID 33802411›Full record

ArticleJournal of fungi (Basel, Switzerland)2021

Three New Derivatives of Zopfinol from

Karen Harms, Andrea Milic, Alberto M Stchigel, Marc Stadler, Frank Surup, Yasmina Marin-Felix

Abstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. New sordarialean lineageIMA fungus · 2026
    Article
  4. Diversity ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  5. Article
  6. IMA fungus · 2025
    Review
  7. Article
  8. Reaping the Chemical Diversity ofJournal of natural products · 2024
    Article
  9. Article
  10. Article
  11. Journal of fungi (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Karen HarmsHelmholtz Centre for Infection Research GmbH and German Centre for Infection Research (DZIF), Department Microbial Drugs, Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany.ORCID 0000-0002-5867-0846
Andrea MilicHelmholtz Centre for Infection Research GmbH and German Centre for Infection Research (DZIF), Department Microbial Drugs, Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany.
Alberto M StchigelMycology Unit, Medical School and Pere Virgili Health Research Institute IISPV, Universitat Rovira i Virgili, C/ Sant Llorenç 21, 43201 Reus, Tarragona, Spain.ORCID 0000-0003-3987-7996
Marc StadlerHelmholtz Centre for Infection Research GmbH and German Centre for Infection Research (DZIF), Department Microbial Drugs, Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany.ORCID 0000-0002-7284-8671
Frank SurupHelmholtz Centre for Infection Research GmbH and German Centre for Infection Research (DZIF), Department Microbial Drugs, Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany.ORCID 0000-0001-5234-8525
Yasmina Marin-FelixHelmholtz Centre for Infection Research GmbH and German Centre for Infection Research (DZIF), Department Microbial Drugs, Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany.

Funding

Alexander von Humboldt Foundation postdoctoral fellowship
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntimicrobialscytotoxicityNaviculisporaceaesecondary metabolitesSordarialessordarins

Identifiers

PMID33802411
PMCPMC8000789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.